FIRST AMENDED AND RESTATED SYNTHETIC CARDIOLIPIN SUPPLY AGREEMENTSynthetic Cardiolipin Supply Agreement • November 14th, 2003 • Neopharm Inc • Biological products, (no disgnostic substances) • Alabama
THIS AGREEMENT is hereby made and entered into as of the day of November, 1999 (the “Effective Date”) by and between Avanti Polar Lipids, Inc., an Alabama corporation having its principal place of business at 700 Industrial Park Drive, Alabaster, Alabama 35007 (“Avanti”), and Neopharm, Inc., a Delaware corporation having a place of business at 100 Corporate North, Suite 215, Bannockburn, Illinois 60015 (“Neopharm”) (Avanti and Neopharm being referred to hereinafter from time to time, collectively, as the “parties”).
CONDITIONAL OPTION AGREEMENT BETWEEN AVANTI POLAR LIPIDS, INC. AND NEOPHARM, INC.Conditional Option Agreement • November 14th, 2003 • Neopharm Inc • Biological products, (no disgnostic substances) • Alabama
THIS CONDITIONAL OPTION AGREEMENT is hereby made and entered into as of this the 26 day of January, 1999 (the “Effective Date”) by and between AVANTI POLAR LIPIDS, INC., an Alabama corporation having its principal place of business at 700 Industrial Park Drive, Alabaster, Alabama 35007 (“Avanti”), and NEOPHARM, INC., a Delaware corporation, having a place of business at 100 Corporate North, Suite 215, Bannockburn, Illinois 60015 (“Neopharm”).
